NURO Archive July 2026

Game-Changing AI-Powered Price & HTA Predictions

Answer your biggest market access questions in minutes, not months. Where traditional methods require resource-intensive analysis, Nuro’s AI-powered platform delivers evidence-based predictions and actionable insights that empower your team to make informed decisions with greater confidence and speed.

Get the product sheet

WHAT IS NURO?

Gain better insights, faster and cut consultancy costs with an AI-powered approach

What is my Phase II asset price potential? What are payers’ evidence expectations for this indication? And what can I do to improve my product’s PMA power? All questions that can be answered in minutes with Nuro™.

Book a demo

Trusted by the best

Discover Nuro

What is Nuro™?

Pharma market access made simple

Nuro transforms the way you make decisions by providing data-based insights on everything from pricing to clinical trials to HTA - all in one place.

1,500,000 data points

Every approved product since 1995 is listed on Nuro - with more than 450 critical data points for each drug.

30+ markets

With a world of market access data at your fingertips, Nuro™ is the go-to solution for global market access teams.

Maximise insights in an instant

From the bigger picture to granular details, compare and contrast all relevant data points side by side with Nuro’s interactive charts and tables, easily exportable in a range of formats.

See your strategy in full colour

Picture where your product sits in the market and present it visually. Nuro creates more than seven different interactive charts to show your product potential alongside industry trends. Easily put them into your company’s branded presentations with a simple click.

Discover Nuro™

Read more about Nuro in our one-page brochure.

Download the brochure

Nuro is for you if you want to:

Take control of data analysis, save time on manual research, cut consultancy costs, accurately assess PMA potential, and make confident decisions, fast.

Nuro

What you get

Market access analysis in minutes

Save critical time uncovering payer evidence expectations, future pricing threats, and a huge number of HTA trends.

Competitive intelligence

What is the evidence landscape in your indication(s)? What brand(s)and evidence packages do payers like in your indication (and what do they not)? How can you navigate pricing in such a space?

450+ data points for every approved product

Dive into the world’s largest pharma database, with in-depth insights for thousands of products.

Model net price evolution

See how the net prices of your key pricing benchmarks may evolve over the next decade in each country.

Generate visuals

Clarify your findings to your teams in easy visual presentations to view the bigger picture, together.

Book a demo

I found Nuro to be incredibly useful to find analogues and price benchmarks when i’m asked to do quick turnaround assessments. I haven’t come across any other solution that comes close.

Senior Director Market Access | UCB

We gain valuable competitive insights through Nuro, which further enhances the quality of our strategic planning.

Adrian Harrington, International Value & Access Lead, Friedreich’s Ataxia, at Biogen

“ Nuro provides a dependable, comprehensive, easy to use resource for both US and ex-US pricing, HTA and regulatory information…all at an affordable price. I find it to be valuable tool for a small biotech with US and Global access needs.”

Vice President of US and Global Payer Strategy of a Clinical-Stage Biotech

WHAT OUR CLIENTS HAVE TO SAY

Industry leaders love what we do

Discover why the world's most successful pharma companies are using our digital solutions to banish manual processess and make smarter decisions.

Break down complex business questions

Learn from the past, predict the future

Compare competitors and past launches to see payers’ thoughts on different evidence packages.

No more cherry-picking analogues

Perfectly match an exhaustive list of analogues in a matter of seconds, whatever your criteria.

Book a demo

FAQs

Learn more about Nuro, who’s it for and how it supports smarter early access and pricing decisions. If you can’t find the answer you are looking for, get in touch with us.

What does NURO do?

Nuro is an AI-enabled early pricing and market access platform that predicts price potential, models likely HTA outcomes, identifies payer evidence gaps, and highlights early payer risk for pipeline and BD assets. It brings analogue data, HTA precedent and competitive intelligence together to produce rapid and defensible early assessments when evidence is limited.

Who is it designed for?

Nuro is designed for Early Market Access, Pricing, and HEOR teams who must shape early pricing, value, and access strategy for pipeline and BD assets years before launch. It supports teams who work with limited early-phase data, tights timelines and high uncertainty by providing a consistent, repeatable way to estimate pricing potential, assess payer risks and build clear recommendations for forecasting, R&D and BD.